| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |